India – According to reports, an expert committee of India’s pharma authority approved emergency use authorization (EUA) for Merck’s Covid-19 pill molnupiravir, as well as the Covovax and corbevax vaccines from Serum Institute of India and Biological E, among other products. According to a report published today, the recommendations of the topic expert group have been sent to the Drugs …